1. Gao, X. and S. Yuan, High density lipoproteins-based therapies for cardiovascular.
2. Navab, M., et al., A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. 2001. 42(8): p. 1308-1317.
3. Hafiane, A. and J.J.B.c. Genest, High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk. 2015. 3: p. 175-188.
4. Kelesidis, T., et al., A biochemical fluorometric method for assessing the oxidative properties of HDL. 2011. 52(12): p. 2341-2351.
5. Kelesidis, T., et al., A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. 2014. 9(11): p. e111716.
6. Van Roosbroeck, R., et al., Synthetic antiferromagnetic nanoparticles as potential contrast agents in MRI. 2014. 8(3): p. 2269-2278.
7. Organization, W.H. [Cardiovascular diseases (CVDs)] 17 May 2017 Cardiovascular diseases (CVDs)]; Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
8. Castelli, W.P., et al., Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. 1977. 30(3): p. 147-169.
9. Sarafian, M.H., et al., Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid Chromatography–Mass spectrometry. 2014. 86(12): p. 5766-5774.
10. Wieland, H. and D.J.J.o.L.R. Seidel, A simple specific method for precipitation of low density lipoproteins. 1983. 24(7): p. 904-909.
11. Seidel, D., P. Alaupovic, and R.J.T.J.o.c.i. Furman, A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. 1969. 48(7): p. 1211-1223.
12. Chen, J.K., S. Labrake‐Farmer, and D.B.J.J.o.c.p. McClure, Purified HDL‐apolipoproteins, A‐I and C‐III, substitute for HDL in promoting the growth of SV40‐transformed REF52 cells in serum‐free medium. 1986. 128(3): p. 413-420.
13. Goux, A., et al., Capillary gel electrophoresis analysis of apolipoproteins AI and A-II in human high-density lipoproteins. 1994. 218(2): p. 320-324.
14. Navab, M., et al., Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. 2000. 41(9): p. 1481-1494.
15. Navab, M., et al., Mechanisms of disease: proatherogenic HDL—an evolving field. 2006. 2(9): p. 504.
16. Ansell, B.J., et al., Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. 2003. 108(22): p. 2751-2756.
17. Undurti, A., et al., Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. 2009. 284(45): p. 30825-30835.
18. Patel, S., et al., Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. 2009. 53(11): p. 962-971.
19. Van Lenten, B.J., et al., Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits. 2007. 48(11): p. 2344-2353.
20. Watson, C.E., et al., Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function. 2011. 52(2): p. 361-373.
21. Zhang, Q., et al., Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway. 2010. 235(9): p. 1082-1092.
22. Dei Cas, A., et al., Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults. 2013. 23(3): p. 272-278.
23. Pletcher, D. and F.C. Walsh, Industrial electrochemistry. 2012: Springer Science & Business Media.
24. Bockris, J.O.M. and A.K. Reddy, Modern electrochemistry 2B: electrodics in chemistry, engineering, biology and environmental science. Vol. 2. 2000: Springer Science & Business Media.
25. Wang, J.J.C.r., Electrochemical glucose biosensors. 2008. 108(2): p. 814-825.
26. Shao, Y., et al., Graphene based electrochemical sensors and biosensors: a review. 2010. 22(10): p. 1027-1036.
27. Bard, A.J., et al., Electrochemical methods: fundamentals and applications. Vol. 2. 1980: wiley New York.
28. Kissinger, P.T. and W.R.J.J.o.C.E. Heineman, Cyclic voltammetry. 1983. 60(9): p. 702.
29. Heinze, J.J.A.C.I.E.i.E., Cyclic voltammetry—“electrochemical spectroscopy”. New analytical methods (25). 1984. 23(11): p. 831-847.
30. Lasia, A., Electrochemical impedance spectroscopy and its applications, in Modern aspects of electrochemistry. 2002, Springer. p. 143-248.
31. Orazem, M.E. and B. Tribollet, Electrochemical impedance spectroscopy. 2017: John Wiley & Sons.
32. Afrasiabi, Z., et al., Transition metal complexes of phenanthrenequinone thiosemicarbazone as potential anticancer agents: synthesis, structure, spectroscopy, electrochemistry and in vitro anticancer activity against human breast cancer cell-line, T47D. 2003. 95(4): p. 306-314.
33. Al-Jaroudi, S.S., et al., Synthesis, spectroscopic characterization, X-ray structure and electrochemistry of new bis (1, 2-diaminocyclohexane) gold (III) chloride compounds and their anticancer activities against PC3 and SGC7901 cancer cell lines. 2014. 38(7): p. 3199-3211.
34. Ronkainen, N.J., H.B. Halsall, and W.R.J.C.S.R. Heineman, Electrochemical biosensors. 2010. 39(5): p. 1747-1763.
35. Paleček, E. and F.J.C.R.i.A.C. Jelen, Electrochemistry of nucleic acids and development of DNA sensors. 2002. 32(3): p. 261-270.
36. Wang, J., et al., Performance of screen-printed carbon electrodes fabricated from different carbon inks. 1998. 43(23): p. 3459-3465.
37. Guan, W.-J., et al., Glucose biosensor based on multi-wall carbon nanotubes and screen printed carbon electrodes. 2005. 21(3): p. 508-512.
38. Lin, Y., et al., Disposable carbon nanotube modified screen‐printed biosensor for amperometric detection of organophosphorus pesticides and nerve agents. 2004. 16(1‐2): p. 145-149.
39. Sun, S. and H.J.J.o.t.A.C.S. Zeng, Size-controlled synthesis of magnetite nanoparticles. 2002. 124(28): p. 8204-8205.
40. Bychkov, Y.A. and E.I.J.J.o.p.C.S.s.p. Rashba, Oscillatory effects and the magnetic susceptibility of carriers in inversion layers. 1984. 17(33): p. 6039.
41. Meissner, W. and R. Ochsenfeld, Ein neuer effekt bei eintritt der supraleitfähigkeit. Naturwissenschaften, 1933. 21(44): p. 787-788.
42. Kittel, C., Introduction to Solid State Physics, 6th edn., 1986. Wiley.
43. Ngo, A., et al., Nanoparticles of: Synthesis and superparamagnetic properties. 1999. 9(4): p. 583-592.
44. Xuan, S., et al., Tuning the grain size and particle size of superparamagnetic Fe3O4 microparticles. 2009. 21(21): p. 5079-5087.
45. Valenzuela, R., et al., Influence of stirring velocity on the synthesis of magnetite nanoparticles (Fe3O4) by the co-precipitation method. 2009. 488(1): p. 227-231.
46. Li, X.-M., et al., Magnetic Fe3O4 nanoparticles: Synthesis and application in water treatment. 2011. 1(1): p. 14-24.
47. Zhou, K., et al., Preparation and application of mediator‐free H2O2 biosensors of graphene‐Fe3O4 composites. 2011. 23(4): p. 862-869.
48. Blaney, L., Magnetite (Fe3O4): Properties, synthesis, and applications. 2007.
49. Yan, A., et al., Solvothermal synthesis and characterization of size-controlled Fe3O4 nanoparticles. 2008. 458(1-2): p. 487-491.
50. Feeney, R.E., G. Blankenhorn, and H.B. Dixon, Carbonyl-amine reactions in protein chemistry, in Advances in protein chemistry. 1975, Elsevier. p. 135-203.
51. Rusmini, F., Z. Zhong, and J.J.B. Feijen, Protein immobilization strategies for protein biochips. 2007. 8(6): p. 1775-1789.
52. Wang, C., et al., Different EDC/NHS activation mechanisms between PAA and PMAA brushes and the following amidation reactions. 2011. 27(19): p. 12058-12068.
53. Birch, J.R. and A.J.J.A.d.d.r. Racher, Antibody production. 2006. 58(5-6): p. 671-685.
54. Edelman, G.M.J.S., Antibody structure and molecular immunology. 1973. 180(4088): p. 830-840.
55. Compton, S.J. and C.G.J.A.b. Jones, Mechanism of dye response and interference in the Bradford protein assay. 1985. 151(2): p. 369-374.
56. Shih, C.-M., et al., Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: a novel index for the prediction of HDL functionality. 2019. 205: p. 17-32.